USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A New Standard of Care May be on the Horizon
19-Sep-2014
North America
Market Research
NE07-01-00-00-00
LS00127-NA-MR_16968
The standard of care, microfracture, does not fulfill long-term needs for patients with chondral defects. In addition, current alternative treatment options are plagued by multiple challenges and limitations. This research service focuses on medicine in the knee cartilage repair market, providing a detailed overview of 9 key products. A product and pipeline assessment is provided for marketed and investigational autologous cell-based therapy, allogenic cell-based therapy, and non-cellular products in the global, US, and European markets. Product profiles are included for companies that are currently or imminently marketing cell-based regenerative therapies and conducting clinical trials in the United States and Europe.
Key Findings
Key Findings (continued)
The Ideal Knee Chondral Defect Repair Solution
Key Companies to Watch
Other Companies to Watch
Market Definitions
Market Opportunity
Market Overview
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Current Cartilage Treatment Options
Significant Unmet Need Continues to Exist for Patients with Grades 3 and 4 Knee Chondral Defects
Technology Improvement Increases Product Utility
Market Drivers and Restraints
Recent Market Developments
Recent Market Developments (continued)
Knee Cartilage Repair Market—Competitive Landscape of Key Products
Knee Cartilage Repair Market—Competitive Landscape of Key Products (continued)
Differentiators for Key Marketed and Pipeline Products
Differentiators for Key Marketed and Pipeline Products (continued)
Differentiators for Key Marketed and Pipeline Products (continued)
Competitive Landscape—Pivotal Phase 3 Trials for Key Products
Competitive Landscape—Post-marketed Trials for Key Products
Global Estimated Approval Timelines for Key Products
Regulatory Pathway for Key Products
Knee Cartilage Repair Market—US Competitive Landscape of all Marketed and Pipeline Products
Marketed Product Analysis of Key Products—US
Pipeline Analysis of Key Products—US
US Competitive Landscape—Pivotal Phase 3 Trials
US Pivotal Phase 3 Trial Details
US Competitive Landscape—Post-marketed Trials
Knee Cartilage Repair Market—Europe Competitive Landscape of all Marketed Products
Knee Cartilage Repair Market—Europe Competitive Landscape of all Pipeline Products
Key Marketed Product Analysis—Europe
Key Marketed Product Analysis—Europe (continued)
Key Product Pipeline Analysis—Europe
Europe Competitive Landscape—Pivotal Phase 3 Trials
Europe Pivotal Phase 3 Trials
Europe Pivotal Phase 3 Trials (continued)
Europe Estimated Approval Timelines
NeoCart—Timelines for Focal Cartilage Defects
NeoCart—Clinical Trial Design Approach and Key Published Data
Product Dashboard—NeoCart
NovoCart 3D—US Timelines for Focal Cartilage Defects
NovoCart 3D—Europe Timelines for Focal Cartilage Defects
NovoCart 3D—Clinical Trial Design Approach and Key Published Data
NovoCart 3D—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—NovoCart 3D
RevaFlex—Timelines for Focal Cartilage Defects
RevaFlex—Clinical Trial Design Approach and Key Published Data
Product Dashboard—RevaFlex
Carticel—Clinical Trial Design Approach and Key Published Data
Carticel—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—Carticel
MACI—Clinical Trial Design Approach and Key Published Data
MACI—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—MACI
ChondroCelect—Clinical Trial Design Approach and Key Published Data
ChondroCelect—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—ChondroCelect
DeNovo NT—Clinical Trial Design Approach and Key Published Data
DeNovo NT—Clinical Trial Design Approach and Key Published Data (continued)
DeNovo NT—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—DeNovo NT
Product Dashboard—Cartiform
Product Dashboard—BioCartilage
Product Dashboard—Cartistem
Key Opinion Leader (KOL) Insights
Key Opinion Leader (KOL) Insights (continued)
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Jennifer Lazar |
| WIP Number | NE07-01-00-00-00 |
| Is Prebook | No |
A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market
$5,000.00
Special Price $3,750.00 save 25 %